GoDubai
  
  
  
  
Citylife > Press Release
  Home Contact us Add to Favourites
Most Recent Postings
More Press Releses
Featured Sections

Event Finder
A daily roundup of exhibitions, promotions and other events in Dubai and the rest of the Emirates.
Submit an Event
Latest Dubai Press Releases >>

 
  Share
Protein-based therapeutics prevent protein aggregation associated with Alzheimer's and other neurodegenerative diseases
 
Fast facts
● Alzheimer's disease, an irreversible and progressive brain disorder, is the most common cause of dementia. 
● A hallmark of Alzheimer's disease is the aggregation of the amyloid-β (Aβ) protein in a process that is toxic to the brain's neurons. As neurons die, this slowly destroys memory and cognitive function. 
● NYUAD researchers have developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the Aβ protein. 
● The paper Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity has been published in Cell Reports Physical Science.
 
Abu Dhabi, UAE, February 7, 2020: A team of researchers, led by NYU Abu Dhabi Assistant Professor of Biology Mazin Magzoub, has developed small proteins called cell-penetrating peptides (CPPs) that prevent the aggregation of the amyloid-β (Aβ) protein associated with Alzheimer's disease. 
 
There is a growing interest in the use of proteins to develop treatments because they are biocompatible, biodegradable, and can selectively bind to specific targets, which reduces the potential for toxicity. Other pharmaceutically-desirable properties of proteins include greater chemical diversity than other biological molecule classes, and ease and low cost of production. However, a significant obstacle to the successful application of most proteins as therapeutics is their poor delivery to target organs and cells. 
 
In a new study, the Magzoub lab in collaboration with Professor and NYU President Andrew Hamilton's lab at NYU New York and Professor Astrid Gräslund's lab at Stockholm University, report that they have engineered CPPs that effectively prevent the aggregation of Aβ. CPPs are a special class of proteins that have the ability to reach all organs, including the brain, and to efficiently enter cells within these organs. Thus, the designed CPPs combine the attractive properties of proteins with potent therapeutic effects and highly efficient delivery to target cells.
 
A broad range of neurodegenerative diseases, including Huntington's, Parkinson's, and Alzheimer's, are caused by the misfolding of disease-specific proteins. Once misfolded, these proteins build up in a process that damages neurons. Previously, the team showed that a naturally-derived CPP was able to protect against abnormal and harmful forms of the protein associated with prion diseases, a class of neurodegenerative disorders that include mad cow disease in cattle and Creutzfeldt-Jakob disease (CJD) in humans. Here, Magzoub and his collaborators extended this approach and specifically applied it to Alzheimer's disease-causing Aβ malformation. 
 
In the paper titled Designed cell-penetrating peptide inhibitors of amyloid-beta aggregation and cytotoxicity, the researchers present the process of designing the Aβ inhibitor CPPs. Using a range of techniques, they then extensively characterized the interactions of the designed CPPs with Aβ. Specifically, they used established aggregation and cell viability assays to determine the effects of the designed CPPs on the aggregation and associated neurotoxicity of Aβ. Simultaneously, they probed the cellular uptake and intracellular distribution of Aβ in the presence of the CPPs with confocal fluorescence microscopy. Finally, they used a combination of experiments and computer simulations to shed light on the mechanism of binding of the CPPs to Aβ. The results show that the designed CPPs stabilize the Aβ protein in a non-aggregated, non-abnormal state, and inhibit Aβ induced neurotoxicity.
 
The CPPs designed in this study effectively target Aβ outside and inside neurons, thereby protecting them against the damage caused by Aβ aggregation. “The designed CPPs represent a novel potential treatment strategy for Alzheimer's disease,” said Magzoub. “These findings also reveal a general underlying principle for inhibition of pathogenic protein aggregation that will facilitate the design of even more potent CPP-based therapeutics for various neurodegenerative diseases.”



Posted by : GoDubai Editorial Team
Viewed 4002 times
Posted on : Saturday, February 8, 2020  
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of GoDubai.com.
Previous Story : Aster DM Healthcare Wins 6 Awards at AHPI Awards 2020
Next Story : Aster Hospitals Dubai achieves diamond level status from Accreditation Canada
Email this article Print this article

Share this article with your friends and followers
NewsVine

Comments

Back to Top  
Most Viewed Press Release posted in the last 7 days
Foreo Set to Break the Beauty Stratosphere According to Experts
Mother's Day Gift Guide 2020
Dina Akesbi joins Clio Beauty on the Professional Beauty GCC Mainstage on 18th Feb!
St Valentine's Day'
6 Trends That Will Dominate Beauty in 2020 According to Foreo
Korea's Number One Beauty Brand Innisfree All Set to Celebrate the Grand Opening...
Jaguar Land Rover on Tour Sheikh Hamdan's Falcons Dominate Hurr Category in Fakh...
V-Motif Western
Costa Coffee Introduces 4u Healthy Food Range Across All UAE Stores in Partnersh...
Rado True Thinline Les CouleursTM Le Corbusier'
Corum Admiral's Cup Legend 47 Worldtimer'
5 Ways To Bring Spring's Top Trends Into Your Wardrobe
HONOR Launches the Iconic Glass Designed HONOR 20 in the UAE
City of Gold Rewarded 200 Jewellery Shoppers With 4 Million Worth of Dubai City ...
Made in Italy: Top Picks from the Latest Deborah Milano Make-Up Range
Introducing Zeitun Premium Face Care Collection
Samsung's New Galaxy S20 Now Available for Pre-Order in the UAE
SPORTMAX 50th Anniversary Capsule Collection
Marks & Spencer, Britain's Best Loved Denim
Dubai Customs Graduates 1st Batch of “Dubai Customs Leaders” Program
Team Abu Dhabi Riders Grab Double Triumph On Dramatic Race Day in Kuwait
Italian Food Exports to the UAE Increases by 11%, Reports ITA Ahead of Italian P...
Aston Martin DBX Makes First Public Appearance in UAE
Union Coop to Sponsor the FAZZA Championships for People of Determination 2020
AS World Group Global Roadshow Promotes Expo 2020 Dubai at 33rd African Union Su...
Arla Foods Introduces New Baby&me Organic Products to Saudi Arabian Market
Spring is in the Air at West Elm
Now at IKEA Dubai you can buy with your time. IKEA's latest innovation converts ...
How to Beat Pigmentation with DERMAdoctor
Create the Ultimate Home Cinema Room With LG
Artificial Intelligence Seen to Play a Significant Role in Driving Success Rate ...
Parmigiano Reggiano Consortium Participates in Gulfood
Buyers Rush for Majid Al Futtaim's First ‘Elan' Townhouses at Tilal Al Ghaf
The Award-winning #burjumanfoodart Festival is Back by Popular Demand!
Heart-Winning Accessories from 2XL Furniture & Home Décor
Hyundai Launches the All New I30 N in South Africa
Rate Hawk is Live with Global Innovations Flagship Product TassPro and Itinerary
Karl Lagerfeld Valentines Special
Achieve Gorgeous and Radiant Skin in Only 90 Seconds
The Bentley Mulliner Bacalar – the Future of Coachbuilding
His Highness Sheikh Hamdan Bin Rashid Al Maktoum Opens Gulfood 2020
Cisco Launches a Comprehensive Security Architecture for Industrial IoT
Abu Dhabi University Celebrates UAE Innovation Month
UAE Community Takes Millions of Steps in Solidarity With Children Who Walk Long ...
“Planet Positive” is Tetra Pak's New Way of Doing Business
Hala and Etisalat Team Up to Strengthen Dubai Taxi Captains' Bond With Their Fam...
Sorbonne University Abu Dhabi (SUAD) to Host Open Day for Prospective Students
Tsitsipas Ready to Launch Another Bid for Dubai Duty Free Tennis Championships
KIZAD to Participate in GulFood 2020 to Showcase Competitive Advantage
Dubai Chamber Honours Top-performing Trading Companies